Sandostatin (octreotide acetate) injection/Sandoz.
The potential benefits of Sandostatin represent an improvement in the quality of living for patients suffering from the symptoms of VIPomas and carcinoid tumors. These patients may have no other therapeutic alternative. Sandostatin may provide these patients with a well-tolerated treatment program that allows them to live a more natural lifestyle. Nurses must be aware of this medication and its administration in order to provide patients requiring Sandostatin therapy with the necessary instruction regarding its use.
Swartz
M L
ML
D002276:Carcinoid Tumor / Q000188:drug therapy*; D006801:Humans; D015282:Octreotide / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D003969:Vipoma / Q000188:drug therapy*
D015282:Octreotide